Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Pain, Postoperative 3Pain 2Neoplasm Metastasis 2Hematologic Neoplasms 2Vesico-Ureteral Reflux 1Ureteral Neoplasms 1Supratentorial Neoplasms 1Pain, Intractable 1Nephrolithiasis 1Neoplasms 1Multiple Myeloma 1Mucositis 1Lymphoma 1Liver Neoplasms 1Leukemia 1Leiomyoma 1Kidney Neoplasms 1Ileus 1Chronic Pain 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Agnosia 1Advanced Malignant Neoplasm 1

Interventions

Cyclophosphamide 61Rituximab 50fludarabine 34Prednisone 33Doxorubicin 28Biopsy 26Vincristine 25Specimen Handling 22Magnetic Resonance Spectroscopy 20Bendamustine Hydrochloride 19pembrolizumab 16Lenalidomide 16obinutuzumab 14fludarabine phosphate 14Etoposide 14venetoclax 13Tacrolimus 11Mycophenolic Acid 10Melphalan 10Dexamethasone 10zanubrutinib 9ibrutinib 9acalabrutinib 9Radiotherapy 9Gemcitabine 9Cytarabine 9Busulfan 9Whole-Body Irradiation 8Mesna 8Filgrastim 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Morphine × 1 year × Clear all
NCT03823534 2026-04-22

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

St. Louis University

Phase 3 Recruiting
60 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Pain, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡